Ivelina Gueorguieva
Lilly Research Laboratories
Department of Drug Disposition
Lilly Research Laboratories
SunninghillRoad
UK
Name/email consistency: high
- Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials. Gueorguieva, I., Jackson, K., Wrighton, S.A., Sinha, V.P., Chien, J.Y. Br. J. Clin. Pharmacol (2010)
- Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage. Gueorguieva, I., Clark, S.R., McMahon, C.J., Scarth, S., Rothwell, N.J., Tyrrell, P.J., Tyrell, P.J., Hopkins, S.J., Rowland, M. Br. J. Clin. Pharmacol (2008)
- A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models. Gueorguieva, I., Ogungbenro, K., Graham, G., Glatt, S., Aarons, L. Comput. Methods. Programs. Biomed (2007)
- Optimal design for multivariate response pharmacokinetic models. Gueorguieva, I., Aarons, L., Ogungbenro, K., Jorga, K.M., Rodgers, T., Rowland, M. J. Pharmacokinet. Pharmacodyn (2006)
- Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS. Gueorguieva, I., Aarons, L., Rowland, M. J. Pharmacokinet. Pharmacodyn (2006)
- Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan. Gueorguieva, I., Nestorov, I.A., Aarons, L., Rowland, M. Pharm. Res. (2005)